Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.33 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.32 |
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19734908 | 0.81 | MVD (0.39) | BTN3A1POLBGAANPSR1ALDH1A1 | |
| SCHEMBL15760474 | 0.81 | LPAR3 (0.41) | BTN3A1POLBGAANPSR1ALDH1A1 | |
| SCHEMBL15223088 | 0.80 | BTN3A1 (0.34) | BTN3A1POLBGAANPSR1ALDH1A1 | |
| SCHEMBL204763 | 0.78 | POLB (0.44) | POLBGAANPSR1ALDH1A1PRKCA | |
| SCHEMBL497177 | 0.78 | LPAR3 (0.46) | BTN3A1LPAR3LPAR1LPAR2PLA2G2C | |
| SCHEMBL15850666 | 0.78 | ALOX15 (0.41) | P2RY10GPR34LPAR3LPAR1LPAR2 | |
| SCHEMBL15246817 | 0.76 | FABP3 (0.36) | P2RY10GPR34LPAR3LPAR1LPAR2 | |
| Hydrochloric Acid SCHEMBL29154726 | 0.76 | POLB (0.43) | POLBGAANPSR1ALDH1A1PRKCA | |
| Bromide SCHEMBL11421248 | 0.76 | LPAR3 (0.44) | BTN3A1LPAR3LPAR1LPAR2PLA2G2C | |
| SCHEMBL7005822 | 0.76 | LPAR3 (0.44) | BTN3A1LPAR3LPAR1LPAR2PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180043029-A1 | STABILIZED POLYMERIC CARRIERS FOR THERAPEUTIC AGENT DELIVERY | UNIVERSITY OF WASHINGTON (US) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180043029-A1 | STABILIZED POLYMERIC CARRIERS FOR THERAPEUTIC AGENT DELIVERY | PAICS, TBCA, PCBP1 | BTN3A1 2219/4885POLB 1408/4885GAA 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.